Menu Search
Equities

Hellenic Dynamics PLC

MG50:FRA

Hellenic Dynamics PLC

Actions
  • Price (EUR)0.0076
  • Today's Change0.00 / 0.00%
  • Shares traded35.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Jul 31 2024 10:50 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Hellenic Dynamics Plc is a United Kingdom-based medical cannabis cultivator. The Company is a cultivator and supplier of finished pharmaceutical standard medical cannabis products with a focus on producing tetrahydrocannabinol (THC) dominant strains of medical cannabis flowers. The Company is involved in the cultivation, production and export of THC dominant strains of dried medical cannabis flowers and flower extracts to the medical cannabis markets across Europe. The Company develops and operates approximately 40,000 square meter active cultivation license from its 195,506 square meter facility located near Thessaloniki in Northern Greece. The Company is capable of producing over 54,000 kilograms (kg) of dried flowers per annum.

  • Revenue in GBP (TTM)--
  • Net income in GBP--
  • Incorporated2007
  • Employees25.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.